Phase 3 Study Evaluating Safety and Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery

NCT02034019 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
247
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Ocular Therapeutix, Inc.